SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES
SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES
Approved
DIN Number
02513781
Drug Class
Human
Market Date
Oct 4, 2021
Company
HC
Sandoz Canada, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02513781
AIG Number0154210001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AX07 DIMETHYL FUMARATE
Product Specifications
Dosage FormCapsule (Delayed Release)
Route of AdministrationOral
AHFS Classification92:20.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
DIMETHYL FUMARATEActive
Strength: 120 MG
Monograph: DIMETHYL FUMARATE